These outcomes, along with a past report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two aid the concept of targeting ACKR3 as a singular approach to modulate the opioid program, which could open new therapeutic avenues for opioid-linked Issues.